JulianaWai-MingEngMD

PubMed

• 1 citations
  Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
  Elkrief, A., Waters, N., Smith, N., Dai, A., Slingerland, J., Aleynick, N., Febles, B., Gogia, P., Socci, N., Lumish, M., Giardina, P., Chaft, J., Eng, J., Motzer, R.,...> ;Cancer Immunology Research. 2024 Mar 4
• 3 citations
  Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consoli...
  Tsai, C., Yang, J., Shaverdian, N., Patel, J., Shepherd, A., Eng, J., Guttmann, D., Yeh, R., Gelblum, D., Namakydoust, A., Preeshagul, I., Modi, S., Seidman, A., Train...> ;Lancet. 2024 Jan 13
• Plasma Circulating Tumor DNA to Assist in the Diagnose of Unknown Primary Malignancy Underlying Choroidal Metastases.
  Francis, J., Levine, S., Canestraro, J., Abramson, D., Eng, J.> ;Retinal Cases & Brief Reports. 2023 Dec 5
• 3 citations
  Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.
  Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y Gelblum, Raja-Elie E Abdulnour, Annemarie F Shepherd, Narek Shaverdian, Abraham J Wu, Joh...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Aug 1
• 40 citations
  Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
  Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust, Paul K Paik, Jamie E Chaft, Gowtham Jayakumaran, A Rose Brannon, Ryma Benayed, Ahmet Zehir, Mar...> ;Nature Medicine. 2022 Nov 1
• 4 citations
  Exceptional Response of a Large and Symptomatic EGFR-Mutant Brain Metastasis to Osimertinib: Case Report and Review of the Literature.
  M. Zeeshan Ozair, Alexandra M Giantini Larsen, Juliana Eng, Nelson S Moss> ;JCO Precision Oncology. 2021 Apr 1
• 1 citations
  Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.
  Jung Julie Kang, Vatche Tchekmedyian, Nader Mohammed, Alisa Rybkin, S. Kitpanit, Ming Fan, Huili Wang, Stephanie Lobaugh, Zhigang Zhang, Anna Lee, Linda Chen, Yao Yu, ...> ;International Journal of Cancer. 2021 Feb 27
• 197 citations
  Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
  Sean McBride, Eric J. Sherman, C. Jillian Tsai, Shrujal S. Baxi, Jahan Aghalar, Juliana Eng, Wanqing Iris Zhi, Daniel C. McFarland, Loren S. Michel, Robert J. Young, R...> ;Journal of Clinical Oncology. 2021 Jan 1
• 154 citations
  COVID-19 in patients with lung cancer
  Jia Luo, Hira Rizvi, Isabel Ruth Preeshagul, Jacklynn V. Egger, David Hoyos, Chaitanya Bandlamudi, Caroline G. McCarthy, Christina Falcon, Adam J. Schoenfeld, Kathryn ...> ;Annals of Oncology. 2020 Oct 1
• 8 citations
  A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
  Paul K. Paik, Rachel Kim, Linda Ahn, Andrew J. Plodkowski, Ai Ni, Mark T.A. Donoghue, Philip Jonsson, Miguel A. Villalona-Calero, Kenneth K. Ng, Daniel C. McFarland, J...> ;Clinical Cancer Research. 2020 Apr 15
• 80 citations
  Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers
  Michael Offin, Romel Somwar, Natasha Rekhtman, Ryma Benayed, Jason C. Chang, Andrew J. Plodkowski, Allan J W Lui, Juliana Eng, Marc K. Rosenblum, Bob T. Li, Gregory J....> ;JCO Precision Oncology. 2018 Sep 4
• Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer.
  Chaft, J. E.,Dagogo-Jack, I.,Santini, F. C.,Eng, J.,Yeap, B. Y.,Izar, B.,Chin, E.,Jones, D. R.,Kris, M. G.,Shaw, A. T.,Gainor, J. F.> ;Lung Cancer. 2018 Jul 24
• 38 citations
  Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers.
  Juliana Eng, Meier Hsu, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Bob T. Li> ;Lung Cancer. 2016 Sep 1
• 74 citations
  Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.
  Juliana Eng, Kaitlin M. Woo, Camelia S. Sima, Andrew J. Plodkowski, Matthew D. Hellmann, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Marc Ladanyi, Alexander Drilon> ;Journal of Thoracic Oncology. 2015 Dec 1
• 44 citations
  Personalized therapy for lung cancer.
  Andre L. Moreira, Juliana Eng> ;Chest. 2014 Dec 1
• Join now to see all